This inventor holds 1 USPTO granted patent. Top assignees: Sk Chemicals, Standigm Inc. Active years: 2026.
Company Filing History:
1 out of 11 
1 out of 3 Years Active: 2026
Title: Nam-Jin Gu: Innovator in TNF-α-Related Disease Treatment
Introduction
Nam-Jin Gu is a notable inventor based in Seongnam-si, South Korea. He has made significant contributions to the field of medicine, particularly in the treatment of TNF-α-related diseases. His innovative approach has the potential to change the landscape of rheumatoid arthritis treatment.
Latest Patents
Nam-Jin Gu holds a patent for a composition aimed at preventing or treating TNF-α-related diseases. The patent, titled "Composition for preventing or treating TNF-α-related disease, comprising hydroflumethiazide as active ingredient," includes hydroflumethiazide or a pharmaceutically acceptable salt as the active ingredient. This composition effectively inhibits the expression or activity of TNF-α and demonstrates superior treatment effects compared to existing agents like methotrexate (MTX) or hydroxychloroquine (HCQ). This innovation can be a valuable option for the prevention or treatment of TNF-α-related diseases.
Career Highlights
Throughout his career, Nam-Jin Gu has worked with prominent companies such as SK Chemicals and Standigm Inc. His experience in these organizations has contributed to his expertise and success in the field of pharmaceutical innovation.
Collaborations
Nam-Jin Gu has collaborated with talented individuals, including Soo Min Lee and Jong-In Kim. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.
Conclusion
Nam-Jin Gu is a distinguished inventor whose work in developing treatments for TNF-α-related diseases showcases his commitment to advancing medical science. His contributions have the potential to significantly improve patient outcomes in the realm of rheumatoid arthritis treatment.